Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis†
References (11)
- et al.
Yersinia enterocolitica gastroenteritis: A prospective study of clinical bacteriologic and epidemiologic features
J Pediatr
(1980) - et al.
Yersinia enterocolitica infections in children
J Pediatr
(1976) - et al.
Yersinia enterocolitica: Clinical observations
- et al.
Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype 0:3
Antimicrob Agents Chemother
(1977) - et al.
Yersinia enterocolitica: In vitro antimicrobial susceptibility
Antimicrob Agents Chemother
(1978)
There are more references available in the full text version of this article.
Cited by (56)
Infectious Diarrhea
2011, Pediatric Gastrointestinal and Liver DiseaseInfectious Diarrhea
2010, Pediatric Gastrointestinal and Liver DiseaseInfectious Enteritis and Proctocolitis and Bacterial Food Poisoning
2010, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and PrintOTHER YERSINIA SPECIES
2009, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth EditionBacterial Enteropathogens
2008, Manson's Tropical Diseases, Twenty-second EditionInfectious Diarrhea
2006, Pediatric Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management
- †
Supported in part by National Health Research and Development Project 605-1396-40, Department of National Health and Welfare of Canada.
- 1
From the Departments of Microbiology and Pediatrics (Infectious Diseases), McGill University-Montreal Children's Hospital Research Institute.
Copyright © 1984 Published by Mosby, Inc.